BioNTech

E232831

biotechnology company pharmaceutical company public company

BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.

Try in SPARQL Jump to: Surface forms Disambiguation Statements Elicitation Referenced by

All labels observed (3)

Label	Occurrences
BioNTech SE	4
BioNTech canonical	3
BioNTech Manufacturing GmbH	1

How this entity was disambiguated

This entity first appeared as the object of triple T2074615 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07

Target entity: BioNTech
Context triple: [Katalin Karikó, employer, BioNTech]

A. Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
B. Samsung Biologics
Samsung Biologics is a South Korean biopharmaceutical company specializing in contract development and manufacturing (CDMO) of biologic drugs for global pharmaceutical and biotech firms.
C. Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
D. Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
E. Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
F. None of above. chosen
G. Unsure - the case is ambiguous/there is not enough information to decide.

NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07

Target entity: BioNTech
Target entity description: BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.

A. Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
B. Samsung Biologics
Samsung Biologics is a South Korean biopharmaceutical company specializing in contract development and manufacturing (CDMO) of biologic drugs for global pharmaceutical and biotech firms.
C. Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
D. Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
E. Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
F. None of above. chosen

Statements (49)

Predicate	Object
instanceOf	biotechnology company ⓘ pharmaceutical company ⓘ public company ⓘ
abbreviation	BioNTech self-linksurface differs ⓘ surface form: BioNTech SE
areaServed	global ⓘ
collaboratesWith	Pfizer ⓘ
country	Germany ⓘ
developed	BNT162b2 ⓘ Pfizer–BioNTech ⓘ surface form: Comirnaty
focusesOn	cancer immunotherapy ⓘ infectious diseases ⓘ mRNA technology ⓘ personalized cancer vaccines ⓘ
foundedBy	Christoph Huber ⓘ Ozlem Tureci ⓘ Ugur Sahin ⓘ
foundedInPeriod	2000s ⓘ
hasClinicalTrialsIn	infectious diseases ⓘ oncology ⓘ
hasCollaboration	Genentech ⓘ Roche ⓘ Sanofi ⓘ
hasKeyPerson	Ozlem Tureci ⓘ Ugur Sahin ⓘ
hasResearchArea	antibodies ⓘ cell therapies ⓘ mRNA therapeutics ⓘ small molecule immunomodulators ⓘ
hasSubsidiaryOrAffiliate	BioNTech self-linksurface differs ⓘ surface form: BioNTech Manufacturing GmbH
hasTechnologyPlatform	CAR-T cell therapy platform ⓘ individualized neoantigen-specific immunotherapy platform ⓘ mRNA vaccine platform ⓘ
headquartersLocation	Germany ⓘ Mainz ⓘ Rhineland-Palatinate ⓘ
industry	biotechnology ⓘ immunotherapy ⓘ oncology ⓘ pharmaceuticals ⓘ
legalForm	Societas Europaea ⓘ
notableFor	developing one of the first authorized mRNA COVID-19 vaccines ⓘ
partnerIn	Pfizer–BioNTech ⓘ surface form: Pfizer–BioNTech COVID-19 vaccine collaboration
positionHeld	Ozlem Tureci – Chief Medical Officer ⓘ Ugur Sahin – Chief Executive Officer ⓘ
productType	mRNA-based COVID-19 vaccine ⓘ
regulatoryApproval	Emergency Use Authorization for COVID-19 vaccine in multiple countries ⓘ Full approval for Comirnaty in several jurisdictions ⓘ
stockExchange	NASDAQ ⓘ
tickerSymbol	BNTX ⓘ

How these facts were elicited

Referenced by (8)

Full triples — surface form annotated when it differs from this entity's canonical label.

Katalin Karikó → employer → BioNTech ⓘ

Pfizer → collaboratedWith → BioNTech ⓘ

Karikó → employer → BioNTech ⓘ

subject surface form: Katalin Karikó

BioNTech → abbreviation → BioNTech self-linksurface differs ⓘ

this entity surface form: BioNTech SE

BioNTech → hasSubsidiaryOrAffiliate → BioNTech self-linksurface differs ⓘ

this entity surface form: BioNTech Manufacturing GmbH

Pfizer–BioNTech → hasParticipant → BioNTech ⓘ

this entity surface form: BioNTech SE

Pfizer–BioNTech → clinicalTrialPhase3Sponsor → BioNTech ⓘ

this entity surface form: BioNTech SE

Pfizer–BioNTech → hasResearchPartner → BioNTech ⓘ

this entity surface form: BioNTech SE

All labels observed (3)

How this entity was disambiguated Show

Statements (49)

How these facts were elicited Show

Referenced by (8)

How this entity was disambiguated

How these facts were elicited